Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

UniQure Net Income 2013-2020 | QURE

For a detailed definition, formula and example for Net Income, check out our new background page here.
UniQure net income from 2013 to 2020. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  
UniQure Annual Net Income
(Millions of US $)
2019 $-124
2018 $-83
2017 $-79
2016 $-73
2015 $-82
2014 $-50
2013 $-36
2012 $-19
UniQure Quarterly Net Income
(Millions of US $)
2020-09-30 $-54
2020-06-30 $-43
2020-03-31 $-28
2019-12-31 $-41
2019-09-30 $-24
2019-06-30 $-31
2019-03-31 $-28
2018-12-31 $-22
2018-09-30 $-22
2018-06-30 $-21
2018-03-31 $-19
2017-12-31 $-27
2017-09-30 $-10
2017-06-30 $-21
2017-03-31 $-20
2016-12-31 $-15
2016-09-30 $-15
2016-06-30 $-21
2016-03-31 $-22
2015-12-31 $-19
2015-09-30 $-29
2015-06-30 $-21
2015-03-31 $-14
2014-12-31 $-0
2014-09-30 $-11
2014-06-30 $-12
2014-03-31 $-11
2013-12-31
2013-09-30
2012-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.730B $0.007B
UNIQURE B.V. is involved in developing gene therapy for patients of genetic or acquired diseases. It offers Glybera for the treatment of lipoprotein lipase deficiency, an orphan metabolic disease. The company's product pipeline includes which are in clinical trials are additional adeno-associated virus consist of AMT-060, AMT-021, AMT-110 and AAV2/glial. UNIQURE B.V. is headquartered in Amsterdam, the Netherlands.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $149.903B 10.69
Amgen (AMGN) United States $146.916B 15.36
CSL (CSLLY) Australia $96.218B 0.00
Gilead Sciences (GILD) United States $85.227B 11.33
Vertex Pharmaceuticals (VRTX) United States $61.551B 28.62
Illumina (ILMN) United States $58.917B 81.03
Regeneron Pharmaceuticals (REGN) United States $57.864B 20.52
Moderna (MRNA) United States $49.519B 0.00
Biogen (BIIB) United States $41.591B 7.39
Alexion Pharmaceuticals (ALXN) United States $34.521B 13.75
Seagen (SGEN) United States $34.515B 90.86
BeiGene (BGNE) Cayman Islands $33.084B 0.00
Genmab (GMAB) Denmark $28.355B 33.53
Genmab (GNMSF) Denmark $27.174B 6.26
BioNTech SE (BNTX) Germany $23.357B 0.00
Exact Sciences (EXAS) United States $22.619B 0.00
Incyte (INCY) United States $21.105B 0.00
Alnylam Pharmaceuticals (ALNY) United States $19.863B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.071B 0.00
Bio-Rad Laboratories (BIO.B) United States $18.067B 68.51
Horizon Therapeutics Public (HZNP) Ireland $17.752B 25.37
Guardant Health (GH) United States $16.329B 0.00
BioMarin Pharmaceutical (BMRN) United States $15.973B 106.01
ARGENX SE-ADR (ARGX) Netherlands $14.456B 0.00
Bio-Techne Corp (TECH) United States $13.771B 88.07
CRISPR Therapeutics AG (CRSP) Switzerland $13.513B 0.00
QIAGEN (QGEN) Netherlands $12.262B 27.61
Repligen (RGEN) United States $11.401B 161.69
Mirati Therapeutics (MRTX) United States $10.700B 0.00
Twist Bioscience (TWST) United States $10.111B 0.00
Fate Therapeutics (FATE) United States $9.510B 0.00
Denali Therapeutics (DNLI) United States $9.295B 0.00
Adaptive Biotechnologies (ADPT) United States $9.145B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.480B 0.00
Ascendis Pharma (ASND) Denmark $8.357B 0.00
Ultragenyx Pharmaceutical (RARE) United States $8.250B 0.00
Novavax (NVAX) United States $7.961B 0.00
Sarepta Therapeutics (SRPT) United States $7.636B 0.00
Acceleron Pharma (XLRN) United States $7.621B 0.00
Galapagos (GLPG) Belgium $7.098B 0.00
Exelixis (EXEL) United States $6.894B 46.29
Halozyme Therapeutics (HALO) United States $6.444B 297.94
NeoGenomics (NEO) United States $6.239B 1873.00
SWEDISH ORP BIO (BIOVF) Sweden $5.932B 17.35
Beam Therapeutics (BEAM) United States $5.928B 0.00
Blueprint Medicines (BPMC) United States $5.808B 19.23
Emergent Biosolutions (EBS) United States $5.717B 18.76
Certara (CERT) United States $5.599B 0.00
Vir Biotechnology (VIR) United States $5.525B 0.00
Amicus Therapeutics (FOLD) United States $5.480B 0.00
Eidos Therapeutics (EIDX) United States $4.860B 0.00
Intellia Therapeutics (NTLA) United States $4.760B 0.00
Arena Pharmaceuticals (ARNA) United States $4.724B 0.00
China Biologic Products (CBPO) China $4.664B 30.22
Editas Medicine (EDIT) United States $4.499B 0.00
Arvinas (ARVN) United States $4.285B 0.00
Insmed (INSM) United States $4.100B 0.00
Legend Biotech (LEGN) United States $4.065B 0.00
MorphoSys AG (MOR) Germany $4.015B 145.33
Reata Pharmaceuticals (RETA) United States $3.753B 0.00
Alkermes (ALKS) Ireland $3.547B 34.83
Bluebird Bio (BLUE) United States $3.178B 0.00
Global Blood Therapeutics (GBT) United States $2.982B 0.00
I-Mab (IMAB) China $2.958B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.856B 0.00
Sorrento Therapeutics (SRNE) United States $2.637B 0.00
Intra-Cellular Therapies (ITCI) United States $2.584B 0.00
Arcus Biosciences (RCUS) United States $2.507B 0.00
Amarin (AMRN) Ireland $2.425B 0.00
Zymeworks (ZYME) Canada $2.359B 0.00
Seres Therapeutics (MCRB) United States $2.318B 0.00
Sangamo Therapeutics (SGMO) United States $2.181B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.177B 0.00
Ligand Pharmaceuticals (LGND) United States $2.172B 56.27
Myriad Genetics (MYGN) United States $2.066B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.057B 17.02
Genetron Holdings (GTH) China $1.955B 0.00
Viela Bio (VIE) United States $1.945B 0.00
PHARMA MAR SA (PHMMF) Spain $1.936B 0.00
NGM Biopharmaceuticals (NGM) United States $1.918B 0.00
Revance Therapeutics (RVNC) United States $1.909B 0.00
NantKwest (NK) United States $1.884B 0.00
Vericel (VCEL) United States $1.805B 0.00
Precigen (PGEN) United States $1.745B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.736B 0.00
Scholar Rock Holding (SRRK) United States $1.733B 0.00
REGENXBIO (RGNX) United States $1.670B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.648B 0.00
Inovio Pharmaceuticals (INO) United States $1.647B 0.00
Castle Biosciences (CSTL) United States $1.642B 0.00
Heska (HSKA) United States $1.577B 0.00
Codexis (CDXS) United States $1.516B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.511B 0.00
Zealand Pharma (ZEAL) Denmark $1.498B 0.00
Mersana Therapeutics (MRSN) United States $1.454B 0.00
Cytokineticsorporated (CYTK) United States $1.414B 0.00
Cellectis S.A (CLLS) France $1.406B 0.00
Alector (ALEC) United States $1.382B 0.00
Travere Therapeutics (TVTX) United States $1.381B 0.00
Adverum Biotechnologies (ADVM) United States $1.357B 0.00
Coherus BioSciences (CHRS) United States $1.320B 8.72
Zealand Pharma (ZLDPF) Denmark $1.287B 0.00
Frequency Therapeutics (FREQ) United States $1.275B 0.00
Antibe Therapeutics (ATBPF) Canada $1.246B 0.00
Epizyme (EPZM) United States $1.244B 0.00
Bionano Genomics (BNGO) United States $1.233B 0.00
Northwest Biotherapeutics (NWBO) United States $1.170B 0.00
Mesoblast (MESO) Australia $1.118B 0.00
Athenex (ATNX) United States $1.066B 0.00
Sutro Biopharma (STRO) United States $1.016B 0.00
Cara Therapeutics (CARA) United States $1.010B 0.00
MiMedx (MDXG) United States $0.994B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.992B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.980B 0.00
Gritstone Oncology (GRTS) United States $0.963B 0.00
Protagonist Therapeutics (PTGX) United States $0.940B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.939B 0.00
Morphic Holding (MORF) United States $0.932B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.922B 0.00
Pharming Group (PHGUF) Netherlands $0.908B 24.17
Compugen (CGEN) Israel $0.907B 0.00
Pliant Therapeutics (PLRX) United States $0.903B 0.00
Kadmon Holdings (KDMN) United States $0.832B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.806B 0.00
VBI Vaccines (VBIV) United States $0.798B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.795B 40.36
Merus (MRUS) Netherlands $0.791B 0.00
Avid Bioservices (CDMO) United States $0.785B 0.00
Precision BioSciences (DTIL) United States $0.768B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.753B 0.00
MannKind (MNKD) United States $0.747B 0.00
Celldex Therapeutics (CLDX) United States $0.741B 0.00
Syros Pharmaceuticals (SYRS) United States $0.740B 0.00
DBV Technologies S.A (DBVT) France $0.715B 0.00
AnaptysBio (ANAB) United States $0.704B 0.00
Albireo Pharma (ALBO) United States $0.695B 0.00
Curis (CRIS) United States $0.679B 0.00
Agenus (AGEN) United States $0.677B 0.00
Sinovac Biotech (SVA) China $0.640B 35.94
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.639B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.632B 0.00
Affimed (AFMD) Germany $0.616B 0.00
MeiraGTx Holdings (MGTX) United States $0.605B 0.00
Clovis Oncology (CLVS) United States $0.579B 0.00
Cel-Sci (CVM) United States $0.574B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.570B 0.00
Anika Therapeutics (ANIK) United States $0.566B 76.60
Dynavax Technologies (DVAX) United States $0.564B 0.00
Five Prime Therapeutics (FPRX) United States $0.564B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.558B 0.00
Prothena (PRTA) Ireland $0.541B 0.00
Geron (GERN) United States $0.540B 0.00
Pandion Therapeutics (PAND) United States $0.537B 0.00
AquaBounty Technologies (AQB) United States $0.518B 0.00
FORTE BIOSCIENC (FBRX) United States $0.512B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.501B 0.00
Amryt Pharma (AMYT) United Kingdom $0.484B 0.00
Spero Therapeutics (SPRO) United States $0.468B 0.00
WAVE Life Sciences (WVE) Singapore $0.463B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.463B 0.00
Starpharma Holdings (SPHRY) Australia $0.461B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.451B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.450B 0.00
Cue Biopharma (CUE) United States $0.437B 0.00
BioDelivery Sciences (BDSI) United States $0.436B 20.52
AC Immune SA (ACIU) Switzerland $0.435B 0.00
UROGEN PHARMA (URGN) United States $0.434B 0.00
Puma Biotechnology (PBYI) United States $0.432B 0.00
XOMA (XOMA) United States $0.426B 0.00
Kala Pharmaceuticals (KALA) United States $0.423B 0.00
ANI Pharmaceuticals (ANIP) United States $0.397B 10.10
Cardiff Oncology (CRDF) United States $0.394B 0.00
AMMO (POWW) United States $0.383B 0.00
CytomX Therapeutics (CTMX) United States $0.377B 0.00
Verastem (VSTM) United States $0.374B 0.00
Athersys (ATHX) United States $0.372B 0.00
Selecta Biosciences (SELB) United States $0.372B 0.00
Innate Pharma S.A (IPHA) France $0.371B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.370B 0.00
NextCure (NXTC) United States $0.357B 0.00
Cellular Biomedicine (CBMG) United States $0.352B 0.00
Arbutus Biopharma (ABUS) United States $0.349B 0.00
Trevena (TRVN) United States $0.338B 0.00
Fortress Biotech (FBIO) United States $0.333B 0.00
Voyager Therapeutics (VYGR) United States $0.332B 8.53
Bellus Health (BLU) Canada $0.311B 0.00
Kamada (KMDA) Israel $0.310B 14.50
Paratek Pharmaceuticals (PRTK) United States $0.300B 0.00
ChromaDex (CDXC) United States $0.295B 0.00
CorMedix Inc (CRMD) United States $0.284B 0.00
PDL BioPharma (PDLI) United States $0.282B 0.00
HOOKIPA Pharma (HOOK) United States $0.273B 0.00
Aptinyx (APTX) United States $0.266B 0.00
OSMOTICA PHARM (OSMT) United States $0.265B 0.00
IBio (IBIO) United States $0.264B 0.00
Checkpoint Therapeutics (CKPT) United States $0.250B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.247B 0.00
Cogent Biosciences (COGT) United States $0.239B 0.00
Palatin Technologies (PTN) United States $0.232B 0.00
ADMA Biologics Inc (ADMA) United States $0.225B 0.00
Theratechnologies (THTX) Canada $0.223B 0.00
Eton Pharmaceuticals (ETON) United States $0.223B 0.00
Cerecor (CERC) United States $0.220B 0.00
GENFIT S.A (GNFT) France $0.214B 0.00
Idera Pharmaceuticals (IDRA) United States $0.205B 0.00
TELA Bio (TELA) United States $0.205B 0.00
Pluristem Therapeutics (PSTI) Israel $0.202B 0.00
Exicure (XCUR) United States $0.199B 0.00
VolitionRX (VNRX) United States $0.198B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Biofrontera AG (BFRA) Germany $0.196B 0.00
Abeona Therapeutics (ABEO) United States $0.196B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.195B 0.00
Strongbridge Biopharma (SBBP) United States $0.194B 0.00
Clearside Biomedical (CLSD) United States $0.187B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.184B 0.00
Nicox SA (NICXF) France $0.182B 0.00
DiaMedica Therapeutics (DMAC) United States $0.176B 0.00
Kindred Biosciences (KIN) United States $0.175B 0.00
Lumos Pharma (LUMO) United States $0.167B 0.00
Cocrystal Pharma (COCP) United States $0.161B 0.00
Oncobiologics (OTLK) United States $0.160B 0.00
VTv Therapeutics (VTVT) United States $0.160B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.157B 0.00
Dyadic (DYAI) United States $0.154B 0.00
Prometic Life Sciences (LMNL) Canada $0.150B 0.00
Protalix BioTherapeutics (PLX) Israel $0.150B 0.00
Evogene (EVGN) Israel $0.149B 0.00
Catalyst Biosciences (CBIO) United States $0.147B 0.00
TRACON Pharmaceuticals (TCON) United States $0.146B 0.00
Enzo Biochem (ENZ) United States $0.142B 0.00
Aptevo Therapeutics (APVO) United States $0.138B 0.00
Synlogic (SYBX) United States $0.134B 0.00
Ecology Coatings (ABVC) United States $0.132B 0.00
Orgenesis (ORGS) United States $0.131B 270.50
Prima BioMed (IMMP) Australia $0.129B 0.00
Liquidia Technologies (LQDA) United States $0.128B 0.00
AIT Therapeutics (XAIR) United States $0.122B 0.00
Applied Genetic Technologies (AGTC) United States $0.121B 0.00
Vascular Biogenics (VBLT) Israel $0.120B 0.00
Celyad SA (CYAD) Belgium $0.120B 0.00
PHASEBIO PHARMA (PHAS) United States $0.117B 0.00
Cyclerion Therapeutics (CYCN) United States $0.113B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.109B 0.00
Organovo Holdings (ONVO) United States $0.109B 0.00
Aytu Bioscience (AYTU) United States $0.109B 0.00
Cidara Therapeutics (CDTX) United States $0.106B 0.00
Seelos Therapeutics (SEEL) United States $0.099B 0.00
Windtree Therapeutics (WINT) United States $0.096B 0.00
Novogen (KZIA) Australia $0.096B 0.00
ARAVIVE, INC (ARAV) United States $0.095B 0.00
CytRx (CYTR) United States $0.093B 0.00
Adocia (ADOCY) France $0.091B 0.00
Stealth BioTherapeutics (MITO) United States $0.084B 40.25
CollPlant Holdings (CLGN) Israel $0.081B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.073B 0.00
Purple Biotech (PPBT) Israel $0.071B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.067B 0.00
AnPac Bio-Medical Science (ANPC) China $0.066B 0.00
Acorda Therapeutics (ACOR) United States $0.064B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.063B 0.00
Edesa Biotech (EDSA) Canada $0.060B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.059B 0.00
Emmaus Life Sciences (EMMA) United States $0.058B 0.00
Genetic Technologies (GENE) Australia $0.058B 0.00
Appili Therapeutics (APLIF) Canada $0.056B 0.00
Vaccinex (VCNX) United States $0.056B 0.00
Cleveland BioLabs (CBLI) United States $0.054B 0.00
BioCardia (BCDA) United States $0.052B 0.00
Yumanity Therapeutics (YMTX) United States $0.052B 0.00
Happiness Biotech Group (HAPP) China $0.050B 0.00
Soligenix (SNGX) United States $0.049B 0.00
Pulmatrix (PULM) United States $0.049B 0.00
Celsion (CLSN) United States $0.048B 0.00
Advaxis (ADXS) United States $0.046B 0.00
Chanticleer Holdings (SONN) United States $0.046B 0.00
AEterna Zentaris (AEZS) United States $0.045B 0.00
Spherix (AIKI) United States $0.041B 0.00
Alimera Sciences (ALIM) United States $0.041B 0.00
ATyr Pharma (LIFE) United States $0.040B 0.00
IMMURON (IMRN) Australia $0.040B 0.00
Prana Biotechnology (ATHE) Australia $0.039B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.035B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.029B 0.00
Neuralstem (SNCA) United States $0.024B 0.00
Titan Pharmaceuticals (TTNP) United States $0.022B 0.00
Cesca Therapeutics (THMO) United States $0.019B 0.00
GeoVax Labs (GOVX) United States $0.017B 0.00
Lexaria Bioscience (LEXX) Canada $0.016B 0.00
Invo BioScience (INVO) United States $0.015B 0.00
BioPharmX (TMBR) United States $0.013B 0.00
CTD Holdings (CYTH) United States $0.010B 0.00
Enveric Biosciences (ENVB) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.004B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00